MYNZ – mainz biomed b.v. (US:NASDAQ)
Stock Stats
News
Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting
Mainz Biomed Provides Review of 2025 Highlights [Yahoo! Finance]
Mainz Biomed Provides Review of 2025 Highlights
Mainz Biomed (NASDAQ:MYNZ) was upgraded by analysts at Wall Street Zen
Mainz Biomed (NASDAQ:MYNZ) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form EFFECT MAINZ BIOMED N.V.
Form 424B5 MAINZ BIOMED N.V.
Form 424B5 MAINZ BIOMED N.V.
Form F-3 MAINZ BIOMED N.V.
Form 424B5 MAINZ BIOMED N.V.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.